Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
School of Public Health, National Defense Medical Center, Taipei, Taiwan.
JAMA Netw Open. 2021 Jan 4;4(1):e2031846. doi: 10.1001/jamanetworkopen.2020.31846.
Obstructive sleep apnea (OSA) has been proposed as a risk factor in infertility. However, to date, the association between OSA and male infertility has not been examined in a population-based study.
To investigate the risk factor of OSA in male infertility and the outcome of OSA treatment for the risk of male infertility.
DESIGN, SETTING, AND PARTICIPANTS: This case-control population-based study collected data from the Longitudinal Health Insurance Database, a subset of the National Health Insurance Research Database in Taiwan. Male patients with a diagnosis of infertility and at least 3 outpatient visits or 1 hospitalization between January 1, 2000, and December 31, 2013, were included and matched by age, sex, and date of infertility diagnosis with individuals without an infertility diagnosis. Data analysis was performed from October 22, 2018, to April 22, 2019.
Patients with male infertility and randomly selected patients without male infertility were matched using a 1:4 propensity score matching ratio.
A primary outcome was the risk factor of OSA (diagnosed through polysomnography). A secondary outcome was the association of the risk of male infertility with OSA exposure time interval (short term, middle term, and long term) and OSA management (ie, none, continuous positive airway pressure, uvulopalatopharyngoplasty, or both).
A total of 4607 male patients with infertility (mean [SD] age, 34.18 [5.44] years) and 18 428 control patients (mean [SD] age, 34.28 [5.81] years) were included. In the multivariate conditional logistic regression analysis, OSA was an independent risk factor associated with infertility (adjusted odds ratio [OR], 1.24; 95% CI, 1.10-1.64; P = .003). The absolute risk was 0.204 (95% CI, 0.092-0.391). For patients with OSA in the group without treatment, the adjusted OR was 1.80 (95% CI, 1.56-2.07; P < .001) for infertility compared with patients without OSA.
Results of this study support the hypothesis that OSA increases the risk of infertility in male patients, and the risk is associated with the OSA exposure time. Furthermore, no OSA management or treatment is associated with a higher infertility risk.
阻塞性睡眠呼吸暂停(OSA)已被提出是不育的一个风险因素。然而,迄今为止,OSA 与男性不育之间的关联尚未在基于人群的研究中进行研究。
研究 OSA 是男性不育的危险因素,以及 OSA 治疗对男性不育风险的影响。
设计、地点和参与者:本病例对照的基于人群的研究从台湾全民健康保险研究资料库的一个子集——长期健康保险资料库中收集数据。纳入了 2000 年 1 月 1 日至 2013 年 12 月 31 日期间至少有 3 次门诊或 1 次住院诊断为不育的男性患者,并根据年龄、性别和不育诊断日期与未诊断为不育的个体进行了匹配。数据分析于 2018 年 10 月 22 日至 2019 年 4 月 22 日进行。
男性不育患者和随机选择的无男性不育患者使用 1:4 的倾向评分匹配比进行匹配。
主要结局是 OSA(通过多导睡眠图诊断)的风险因素。次要结局是 OSA 暴露时间间隔(短期、中期和长期)和 OSA 管理(即无、持续气道正压通气、悬雍垂腭咽成形术或两者兼有)与男性不育风险的相关性。
共纳入 4607 名男性不育患者(平均[SD]年龄,34.18[5.44]岁)和 18428 名对照患者(平均[SD]年龄,34.28[5.81]岁)。在多变量条件逻辑回归分析中,OSA 是与不育相关的独立危险因素(调整后的优势比[OR],1.24;95%CI,1.10-1.64;P = .003)。绝对风险为 0.204(95%CI,0.092-0.391)。对于未治疗的 OSA 组中的患者,与无 OSA 的患者相比,不育的调整后 OR 为 1.80(95%CI,1.56-2.07;P < .001)。
本研究结果支持 OSA 增加男性患者不育风险的假设,且风险与 OSA 暴露时间有关。此外,无 OSA 管理或治疗与更高的不育风险相关。